Gaps in insurance coverage for pediatric patients with acute lymphoblastic Leukemia

Rochelle R. Smits-Seemann, Sapna Kaul, Aimee O. Hersh, Mark N. Fluchel, Kenneth M. Boucher, Rochelle R. Smits-Seemann

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Purpose Continuous insurance coverage is an important component of effective health care. Evaluation of insurance gaps in pediatric cancer care is an understudied area. Methods Weconducted a retrospective analysis of payer data from outpatient oncology encounters at Primary Children's Hospital (Salt Lake City, UT) over the first 2 years of therapy for pediatric patients with acute lymphoblastic leukemia diagnosed from 1998 to 2010 (N = 380). Using logistic regression, we evaluated demographic and clinical predictors (age at diagnosis, sex, ethnicity, high/standard acute lymphoblastic leukemia risk, and rural/urban county of residence at diagnosis) of a gap in health insurance. Results Themedian age at diagnosiswas4years (interquartile range,3to8years),and172patients (45%) were girls. In the first 2 years of treatment, 45 patients (12%) experienced a gap in health insurance. The odds of having a gap in insurance coverage decreased by 16% each year from 1998 to 2010 (odds ratio, 0.84; 95% CI, 0.76 to 0.93; test for trend, P =.001). Public insurance at diagnosis was associated with a four-fold increased likelihood of experiencing an insurance gap (odds ratio, 4.09; 95% CI, 1.98 to 8.44; P<001) compared with patients with private insurance at diagnosis. Conclusion Gaps in insurance coverage during pediatric cancer treatment are not uncommon, which highlights the importance of discussing insurance status at diagnosis and throughout a patient's treatment course to help patients and their families prepare for any changes and avoid unnecessary financial burden. Future research should focus on examining the effect of insurance gaps on patient outcomes and evaluating likelihood of gaps in insurance after health care reform.

Original languageEnglish (US)
Pages (from-to)e207-e214
JournalJournal of Oncology Practice
Volume12
Issue number2
DOIs
StatePublished - Feb 1 2016
Externally publishedYes

Fingerprint

Insurance Coverage
Insurance
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Pediatrics
Health Insurance
Odds Ratio
Health Care Reform
Therapeutics
Neoplasms
Outpatients
Logistic Models
Demography
Delivery of Health Care

ASJC Scopus subject areas

  • Oncology
  • Oncology(nursing)
  • Health Policy

Cite this

Smits-Seemann, R. R., Kaul, S., Hersh, A. O., Fluchel, M. N., Boucher, K. M., & Smits-Seemann, R. R. (2016). Gaps in insurance coverage for pediatric patients with acute lymphoblastic Leukemia. Journal of Oncology Practice, 12(2), e207-e214. https://doi.org/10.1200/JOP.2015.005686

Gaps in insurance coverage for pediatric patients with acute lymphoblastic Leukemia. / Smits-Seemann, Rochelle R.; Kaul, Sapna; Hersh, Aimee O.; Fluchel, Mark N.; Boucher, Kenneth M.; Smits-Seemann, Rochelle R.

In: Journal of Oncology Practice, Vol. 12, No. 2, 01.02.2016, p. e207-e214.

Research output: Contribution to journalArticle

Smits-Seemann, RR, Kaul, S, Hersh, AO, Fluchel, MN, Boucher, KM & Smits-Seemann, RR 2016, 'Gaps in insurance coverage for pediatric patients with acute lymphoblastic Leukemia', Journal of Oncology Practice, vol. 12, no. 2, pp. e207-e214. https://doi.org/10.1200/JOP.2015.005686
Smits-Seemann, Rochelle R. ; Kaul, Sapna ; Hersh, Aimee O. ; Fluchel, Mark N. ; Boucher, Kenneth M. ; Smits-Seemann, Rochelle R. / Gaps in insurance coverage for pediatric patients with acute lymphoblastic Leukemia. In: Journal of Oncology Practice. 2016 ; Vol. 12, No. 2. pp. e207-e214.
@article{c9a75bd26c6e417d9d63abcf0d4a858f,
title = "Gaps in insurance coverage for pediatric patients with acute lymphoblastic Leukemia",
abstract = "Purpose Continuous insurance coverage is an important component of effective health care. Evaluation of insurance gaps in pediatric cancer care is an understudied area. Methods Weconducted a retrospective analysis of payer data from outpatient oncology encounters at Primary Children's Hospital (Salt Lake City, UT) over the first 2 years of therapy for pediatric patients with acute lymphoblastic leukemia diagnosed from 1998 to 2010 (N = 380). Using logistic regression, we evaluated demographic and clinical predictors (age at diagnosis, sex, ethnicity, high/standard acute lymphoblastic leukemia risk, and rural/urban county of residence at diagnosis) of a gap in health insurance. Results Themedian age at diagnosiswas4years (interquartile range,3to8years),and172patients (45{\%}) were girls. In the first 2 years of treatment, 45 patients (12{\%}) experienced a gap in health insurance. The odds of having a gap in insurance coverage decreased by 16{\%} each year from 1998 to 2010 (odds ratio, 0.84; 95{\%} CI, 0.76 to 0.93; test for trend, P =.001). Public insurance at diagnosis was associated with a four-fold increased likelihood of experiencing an insurance gap (odds ratio, 4.09; 95{\%} CI, 1.98 to 8.44; P<001) compared with patients with private insurance at diagnosis. Conclusion Gaps in insurance coverage during pediatric cancer treatment are not uncommon, which highlights the importance of discussing insurance status at diagnosis and throughout a patient's treatment course to help patients and their families prepare for any changes and avoid unnecessary financial burden. Future research should focus on examining the effect of insurance gaps on patient outcomes and evaluating likelihood of gaps in insurance after health care reform.",
author = "Smits-Seemann, {Rochelle R.} and Sapna Kaul and Hersh, {Aimee O.} and Fluchel, {Mark N.} and Boucher, {Kenneth M.} and Smits-Seemann, {Rochelle R.}",
year = "2016",
month = "2",
day = "1",
doi = "10.1200/JOP.2015.005686",
language = "English (US)",
volume = "12",
pages = "e207--e214",
journal = "Journal of Oncology Practice",
issn = "1554-7477",
publisher = "American Society of Clinical Oncology",
number = "2",

}

TY - JOUR

T1 - Gaps in insurance coverage for pediatric patients with acute lymphoblastic Leukemia

AU - Smits-Seemann, Rochelle R.

AU - Kaul, Sapna

AU - Hersh, Aimee O.

AU - Fluchel, Mark N.

AU - Boucher, Kenneth M.

AU - Smits-Seemann, Rochelle R.

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Purpose Continuous insurance coverage is an important component of effective health care. Evaluation of insurance gaps in pediatric cancer care is an understudied area. Methods Weconducted a retrospective analysis of payer data from outpatient oncology encounters at Primary Children's Hospital (Salt Lake City, UT) over the first 2 years of therapy for pediatric patients with acute lymphoblastic leukemia diagnosed from 1998 to 2010 (N = 380). Using logistic regression, we evaluated demographic and clinical predictors (age at diagnosis, sex, ethnicity, high/standard acute lymphoblastic leukemia risk, and rural/urban county of residence at diagnosis) of a gap in health insurance. Results Themedian age at diagnosiswas4years (interquartile range,3to8years),and172patients (45%) were girls. In the first 2 years of treatment, 45 patients (12%) experienced a gap in health insurance. The odds of having a gap in insurance coverage decreased by 16% each year from 1998 to 2010 (odds ratio, 0.84; 95% CI, 0.76 to 0.93; test for trend, P =.001). Public insurance at diagnosis was associated with a four-fold increased likelihood of experiencing an insurance gap (odds ratio, 4.09; 95% CI, 1.98 to 8.44; P<001) compared with patients with private insurance at diagnosis. Conclusion Gaps in insurance coverage during pediatric cancer treatment are not uncommon, which highlights the importance of discussing insurance status at diagnosis and throughout a patient's treatment course to help patients and their families prepare for any changes and avoid unnecessary financial burden. Future research should focus on examining the effect of insurance gaps on patient outcomes and evaluating likelihood of gaps in insurance after health care reform.

AB - Purpose Continuous insurance coverage is an important component of effective health care. Evaluation of insurance gaps in pediatric cancer care is an understudied area. Methods Weconducted a retrospective analysis of payer data from outpatient oncology encounters at Primary Children's Hospital (Salt Lake City, UT) over the first 2 years of therapy for pediatric patients with acute lymphoblastic leukemia diagnosed from 1998 to 2010 (N = 380). Using logistic regression, we evaluated demographic and clinical predictors (age at diagnosis, sex, ethnicity, high/standard acute lymphoblastic leukemia risk, and rural/urban county of residence at diagnosis) of a gap in health insurance. Results Themedian age at diagnosiswas4years (interquartile range,3to8years),and172patients (45%) were girls. In the first 2 years of treatment, 45 patients (12%) experienced a gap in health insurance. The odds of having a gap in insurance coverage decreased by 16% each year from 1998 to 2010 (odds ratio, 0.84; 95% CI, 0.76 to 0.93; test for trend, P =.001). Public insurance at diagnosis was associated with a four-fold increased likelihood of experiencing an insurance gap (odds ratio, 4.09; 95% CI, 1.98 to 8.44; P<001) compared with patients with private insurance at diagnosis. Conclusion Gaps in insurance coverage during pediatric cancer treatment are not uncommon, which highlights the importance of discussing insurance status at diagnosis and throughout a patient's treatment course to help patients and their families prepare for any changes and avoid unnecessary financial burden. Future research should focus on examining the effect of insurance gaps on patient outcomes and evaluating likelihood of gaps in insurance after health care reform.

UR - http://www.scopus.com/inward/record.url?scp=85031981727&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85031981727&partnerID=8YFLogxK

U2 - 10.1200/JOP.2015.005686

DO - 10.1200/JOP.2015.005686

M3 - Article

VL - 12

SP - e207-e214

JO - Journal of Oncology Practice

JF - Journal of Oncology Practice

SN - 1554-7477

IS - 2

ER -